Literature DB >> 27184401

Mule Regulates the Intestinal Stem Cell Niche via the Wnt Pathway and Targets EphB3 for Proteasomal and Lysosomal Degradation.

Carmen Dominguez-Brauer1, Zhenyue Hao1, Andrew J Elia1, Jérôme M Fortin1, Robert Nechanitzky1, Patrick M Brauer2, Yi Sheng3, Miyeko D Mana4, Iok In Christine Chio5, Jillian Haight1, Aaron Pollett6, Robert Cairns1, Leanne Tworzyanski1, Satoshi Inoue1, Colin Reardon7, Ana Marques1, Jennifer Silvester1, Maureen A Cox1, Andrew Wakeham1, Omer H Yilmaz4, David M Sabatini8, Johan H van Es9, Hans Clevers9, Toshiro Sato10, Tak W Mak11.   

Abstract

The E3 ubiquitin ligase Mule is often overexpressed in human colorectal cancers, but its role in gut tumorigenesis is unknown. Here, we show in vivo that Mule controls murine intestinal stem and progenitor cell proliferation by modulating Wnt signaling via c-Myc. Mule also regulates protein levels of the receptor tyrosine kinase EphB3 by targeting it for proteasomal and lysosomal degradation. In the intestine, EphB/ephrinB interactions position cells along the crypt-villus axis and compartmentalize incipient colorectal tumors. Our study thus unveils an important new avenue by which Mule acts as an intestinal tumor suppressor by regulation of the intestinal stem cell niche.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27184401      PMCID: PMC5193118          DOI: 10.1016/j.stem.2016.04.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  36 in total

1.  Crystal structure of an Eph receptor-ephrin complex.

Authors:  J P Himanen; K R Rajashankar; M Lackmann; C A Cowan; M Henkemeyer; D B Nikolov
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

2.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation.

Authors:  I M de Alboran; R C O'Hagan; F Gärtner; B Malynn; L Davidson; R Rickert; K Rajewsky; R A DePinho; F W Alt
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

3.  Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice.

Authors:  Ning Kon; Jiayun Zhong; Li Qiang; Domenico Accili; Wei Gu
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

4.  A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable.

Authors:  Hua Tian; Brian Biehs; Søren Warming; Kevin G Leong; Linda Rangell; Ophir D Klein; Frederic J de Sauvage
Journal:  Nature       Date:  2011-09-18       Impact factor: 49.962

Review 5.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

6.  c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium.

Authors:  Michael D Bettess; Nicole Dubois; Mark J Murphy; Christelle Dubey; Catherine Roger; Sylvie Robine; Andreas Trumpp
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Identification and characterization of the familial adenomatous polyposis coli gene.

Authors:  J Groden; A Thliveris; W Samowitz; M Carlson; L Gelbert; H Albertsen; G Joslyn; J Stevens; L Spirio; M Robertson
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.

Authors:  Vanesa Muncan; Owen J Sansom; Leon Tertoolen; Toby J Phesse; Harry Begthel; Elena Sancho; Alicia M Cole; Alex Gregorieff; Ignacio Moreno de Alboran; Hans Clevers; Alan R Clarke
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

10.  The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

Authors:  Zhenyue Hao; Gordon S Duncan; Yu-Wen Su; Wanda Y Li; Jennifer Silvester; Claire Hong; Han You; Dirk Brenner; Chiara Gorrini; Jillian Haight; Andrew Wakeham; Annick You-Ten; Susan McCracken; Andrew Elia; Qinxi Li; Jacqui Detmar; Andrea Jurisicova; Elias Hobeika; Michael Reth; Yi Sheng; Philipp A Lang; Pamela S Ohashi; Qing Zhong; Xiaodong Wang; Tak W Mak
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

View more
  14 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 2.  Atoh1 regulation in the cochlea: more than just transcription.

Authors:  Yen-Fu Cheng
Journal:  J Zhejiang Univ Sci B       Date:  2017-07-13       Impact factor: 3.066

3.  Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.

Authors:  Huairui Yuan; Ni Li; Da Fu; Jiale Ren; Jingyi Hui; Junjie Peng; Yongfeng Liu; Tong Qiu; Min Jiang; Qiang Pan; Ying Han; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-08-21       Impact factor: 14.808

4.  E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.

Authors:  Carmen Dominguez-Brauer; Rahima Khatun; Andrew J Elia; Kelsie L Thu; Parameswaran Ramachandran; Shakiba P Baniasadi; Zhenyue Hao; Lisa D Jones; Jillian Haight; Yi Sheng; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

Review 5.  Ubiquitin ligases in oncogenic transformation and cancer therapy.

Authors:  Daniela Senft; Jianfei Qi; Ze'ev A Ronai
Journal:  Nat Rev Cancer       Date:  2017-12-15       Impact factor: 60.716

6.  Recent Advances in Intestinal Stem Cells.

Authors:  Laura R McCabe; Narayanan Parameswaran
Journal:  Curr Mol Biol Rep       Date:  2017-07-13

7.  HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.

Authors:  Kevin B Myant; Patrizia Cammareri; Michael C Hodder; Jimi Wills; Alex Von Kriegsheim; Balázs Győrffy; Mamun Rashid; Simona Polo; Elena Maspero; Lynsey Vaughan; Basanta Gurung; Evan Barry; Angeliki Malliri; Fernando Camargo; David J Adams; Antonio Iavarone; Anna Lasorella; Owen J Sansom
Journal:  EMBO Mol Med       Date:  2017-02       Impact factor: 12.137

Review 8.  Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets.

Authors:  Yungang Wang; Shouyan Deng; Jie Xu
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

9.  Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer.

Authors:  Seong Hye Park; Min Jee Jo; Bo Ram Kim; Yoon A Jeong; Yoo Jin Na; Jung Lim Kim; Soyeon Jeong; Hye Kyeong Yun; Dae Yeong Kim; Bu Gyeom Kim; Sang Hee Kang; Sang Cheul Oh; Dae-Hee Lee
Journal:  Theranostics       Date:  2019-04-12       Impact factor: 11.556

10.  Hepatic PPARα function is controlled by polyubiquitination and proteasome-mediated degradation through the coordinated actions of PAQR3 and HUWE1.

Authors:  Zilong Zhao; Daqian Xu; Zheng Wang; Lin Wang; Ruomei Han; Zhenzhen Wang; Lujian Liao; Yan Chen
Journal:  Hepatology       Date:  2018-04-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.